Share on LinkedInShare on LinkedIn

ARTICLE · 20 AUGUST 2018

Irish Commercial Court Refuses To Suspend Patent Litigation

The Irish Commercial Court has departed from a long standing precedent and refused to suspend national patent revocation proceedings whilst parallel opposition proceedings are ongoing in the European

IrelandIntellectual Property

The Irish Commercial Court has departed from a long standing precedent and refused to suspend national patent revocation proceedings whilst parallel opposition proceedings are ongoing in the European Patents Office (the "EPO"). This has the potential to result in an increase in litigating national patents devolved from European patents in Ireland. In this article, IP litigator Michael Finn highlights some of the key aspects of the decision.

Some background facts - the basis for the application to stay the proceedings

Eisai are the holders of an Irish Patent, derived from a European Patent under the European Patent Convention, which includes compounds that may be used to treat Alzheimer's disease. Opposition proceedings in the EPO are currently under appeal to the Technical Bureau of Appeal ("TBA").

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from